FI854268A7 - Kiteiset aminometyyliyhdisteet. - Google Patents

Kiteiset aminometyyliyhdisteet. Download PDF

Info

Publication number
FI854268A7
FI854268A7 FI854268A FI854268A FI854268A7 FI 854268 A7 FI854268 A7 FI 854268A7 FI 854268 A FI854268 A FI 854268A FI 854268 A FI854268 A FI 854268A FI 854268 A7 FI854268 A7 FI 854268A7
Authority
FI
Finland
Prior art keywords
crystalline
aminomethyl compounds
aminomethyl
compounds
crystalline aminomethyl
Prior art date
Application number
FI854268A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI854268L (fi
FI854268A0 (fi
Inventor
Peter Schneider
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of FI854268A0 publication Critical patent/FI854268A0/fi
Publication of FI854268L publication Critical patent/FI854268L/fi
Publication of FI854268A7 publication Critical patent/FI854268A7/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/88—Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/09—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/568—Four-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI854268A 1984-11-02 1985-10-30 Kiteiset aminometyyliyhdisteet. FI854268A7 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH526684 1984-11-02

Publications (3)

Publication Number Publication Date
FI854268A0 FI854268A0 (fi) 1985-10-30
FI854268L FI854268L (fi) 1986-05-03
FI854268A7 true FI854268A7 (fi) 1986-05-03

Family

ID=4290719

Family Applications (1)

Application Number Title Priority Date Filing Date
FI854268A FI854268A7 (fi) 1984-11-02 1985-10-30 Kiteiset aminometyyliyhdisteet.

Country Status (17)

Country Link
US (1) US4761408A (enExample)
EP (1) EP0181571A1 (enExample)
JP (1) JPS61165390A (enExample)
KR (1) KR890001009B1 (enExample)
AU (1) AU580636B2 (enExample)
DD (1) DD242408A5 (enExample)
DK (1) DK505485A (enExample)
ES (1) ES8701765A1 (enExample)
FI (1) FI854268A7 (enExample)
GR (1) GR852625B (enExample)
HU (1) HUT39184A (enExample)
IL (1) IL76897A (enExample)
NO (1) NO854364L (enExample)
NZ (1) NZ214046A (enExample)
PH (1) PH23259A (enExample)
PT (1) PT81411B (enExample)
ZA (1) ZA858402B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD268946A5 (de) * 1986-04-29 1989-06-14 ����`��@���k�� Verfahren zur herstellung des (5r,6s)-2-aminopethyl-6-[(1r)-1-hydroxyaethyl]-2-penem-3-carbonsaeure-minophyrats
IE60588B1 (en) * 1986-07-30 1994-07-27 Sumitomo Pharma Carbapenem compound in crystalline form, and its production and use
GB8818789D0 (en) * 1988-08-08 1988-09-07 Erba Carlo Spa Crystalline(5r 6s)-2-carbamoyloxymethyl-6-((1r)-hydroxyethyl)-2-penem-carboxylic acid & pharmaceutical formulation
US20040202714A1 (en) * 1999-10-12 2004-10-14 Daiichi Suntory Pharma Co., Ltd. Oral pharmaceutical composition
DE60008497T2 (de) * 1999-10-12 2004-12-02 Daiichi Suntory Pharma Co., Ltd. Arzneimittel zur oralen verabreichung

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0003960B1 (de) * 1978-02-02 1983-06-29 Ciba-Geigy Ag 6-Substituierte Thia-Azaverbindungen, ihre Herstellung und diese enthaltende pharmazeutische Präparate
US4272437A (en) * 1978-12-18 1981-06-09 Bristol-Myers Company Antibacterial agents, and 4-thio azetidinone intermediates
IL59081A0 (en) * 1979-01-10 1980-05-30 Schering Corp 2-penem compounds and a method for preparing them
AT368506B (de) * 1979-02-24 1982-10-25 Erba Farmitalia Verfahren zur herstellung von neuen penemcarbonsaeuren und deren salzen
US4386030A (en) * 1979-12-31 1983-05-31 Merck & Co., Inc. Process for preparing 6-(1'-hydroxyethyl)-2-substituted-pen-2-em-3-carboxylic acid
US4347183A (en) * 1981-02-02 1982-08-31 Schering Corporation Process for the synthesis of penems and carbapenems
JPS588084A (ja) * 1981-07-08 1983-01-18 Takeda Chem Ind Ltd (6r)−置換−(5r)−ペネム−3−カルボン酸誘導体およびその製造法
DE3277696D1 (en) * 1981-07-15 1987-12-23 Sumitomo Pharma Carboxylic beta-lactam compounds and the preparation thereof
US4540580A (en) * 1982-11-16 1985-09-10 Schering Corporation 2-[(1'R)-1'-Aminoalkyl]penems
EP0125208A1 (de) * 1983-05-06 1984-11-14 Ciba-Geigy Ag Aminoniederalkyl-penem-Verbindungen, Verfahren zu ihrer Herstellung, pharmazeutische Präparate, welche diese Verbindungen enthalten, und Verwendung von letzteren
EP0132101A1 (en) * 1983-07-14 1985-01-23 Pfizer Inc. 2-Heterocycloalkylthiopenem derivatives
US4656165A (en) * 1983-09-02 1987-04-07 Ciba-Geigy Corporation Aminomethyl penem compounds
US4634556A (en) * 1985-05-10 1987-01-06 Schering Corporation Crystalline sodium (5R, 6S, 8R)-6-(1-hydroxyethyl)-2-(2-carbamoyloxyethylthio)-penem-3-carboxylate and process for making same

Also Published As

Publication number Publication date
DK505485D0 (da) 1985-11-01
PT81411A (en) 1985-11-01
FI854268L (fi) 1986-05-03
PT81411B (en) 1987-08-04
KR860004064A (ko) 1986-06-16
DK505485A (da) 1986-05-03
NZ214046A (en) 1988-09-29
GR852625B (enExample) 1986-03-03
KR890001009B1 (ko) 1989-04-18
AU580636B2 (en) 1989-01-19
NO854364L (no) 1986-05-05
ZA858402B (en) 1986-06-25
IL76897A (en) 1989-10-31
US4761408A (en) 1988-08-02
JPS61165390A (ja) 1986-07-26
AU4930685A (en) 1986-05-08
DD242408A5 (de) 1987-01-28
EP0181571A1 (de) 1986-05-21
HUT39184A (en) 1986-08-28
ES548435A0 (es) 1986-12-01
ES8701765A1 (es) 1986-12-01
IL76897A0 (en) 1986-02-28
FI854268A0 (fi) 1985-10-30
PH23259A (en) 1989-06-16

Similar Documents

Publication Publication Date Title
DE3583287D1 (de) Substituierte isochinolinsulfonyl-verbindungen.
FI853923A7 (fi) Substituoidut propaani- fosfonihappoyhdisteet.
FI853313A0 (fi) Speciallins foer glasoegon.
DE3578166D1 (de) Fluessigkristalline substituierte biphenylester.
FI850140A7 (fi) Kemiallisia yhdisteitä.
FI853736A7 (fi) Triatsolokinatsoliiniyhdisteet.
DE3585434D1 (de) Cephalosporinverbindungen.
FI854811A7 (fi) Skaerhuvud foer traodkapare.
DE3583751D1 (de) Cephalosporinverbindungen.
FI852755A7 (fi) Aminofenoliyhdisteet.
FI852289A7 (fi) Antibakteeriset yhdisteet.
FI851592A7 (fi) Antibakteeriset yhdisteet.
DE3580183D1 (de) Antibakterielle chinobenzoxazin-verbindungen.
DE3482255D1 (de) Kristallines silicophosphoaluminat.
DE3585137D1 (de) Kristallinische cephalosporinantibiotika.
DK17385D0 (da) Oxadiazinonforbindelser
FI852319A7 (fi) 13-atsa-14-okso-tromboksaani A2-analogeja.
FI853304A7 (fi) Yhdisteet
DK163662C (da) N-chlorsulfonyl-2-oxindol-1-carboxamid-forbindelser
FI852768A7 (fi) Yhdisteet.
NO853435L (no) Substituerte 7-oksomitosaner.
FI843427A7 (fi) Aminometyyliyhdisteet.
DK437685D0 (da) 1alfa,25-dihydroxy-22z-dehydrovitamin d forbindelser
DE3578424D1 (de) Quino-benzothiazin-antibakterielle verbindungen.
FI854268A0 (fi) Kristalliniska aminometylfoereningar.

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: CIBA-GEIGY AG